Pulmonary edema of mountaineers clinical trials
The registry lists 20 studies for Pulmonary edema of mountaineers across 5 countries. 2 are recruiting or about to start. 19 of them are mainly about Pulmonary edema of mountaineers (how this is decided). Per ClinicalTrials.gov, last updated 2026-01-22.
Get an email when these change. Save the Pulmonary edema of mountaineers studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Who runs them
University of Zurich (16) · Norwegian Armed Forces Medical Service (1) · Richard Moon (1) · Thies Schroeder (1) · Novlead Inc. (1)
What is being tested here
Drugs under test in Pulmonary edema of mountaineers studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Riociguat | 0 | 0 | 1 |
| Aminophylline | 0 | 0 | 1 |
| Ambrisentan | 0 | 0 | 1 |
| Theophylline | 0 | 0 | 1 |
| Bambuterol | 0 | 0 | 1 |
Who these studies take
Of the 1 Pulmonary edema of mountaineers studies recruiting now, 0 (0%) set no upper age limit and 1 (100%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 0 (0%) | 0 (0%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 20 studies, recruiting or not: 20% stop at 75 or younger and 20% at 65; 25% take children; 0% are for women only and 0% for men only; 30% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Pulmonary edema of mountaineers studies take
Of 11 interventional studies with no phase under Pulmonary edema of mountaineers, half reached primary completion within 5 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 5 mo2–5 · 11 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
Studies
Recruiting first, then most recently updated. Showing 20 of 20. search them.
- Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE)RecruitingNCT06852924Not applicable1 country
- HAPH Registry: Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.Not yet recruitingNCT06489730
- High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), 6MWT Assessed at High Altitude (3200m) vs Low Altitude (760m)CompletedNCT06489691Not applicable1 country
- High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), SDB Assessed at HA (3200 m) vs LA (760 m)CompletedNCT06489717Not applicable1 country
- High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)CompletedNCT06489704Not applicable1 country
- Highlanders With High Altitude Pulmonary Hypertension (HAPH), 6 Minute Walk Distance (6MWD) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)CompletedNCT06489743Not applicable1 country
- Highlanders With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Arterial Pressure (PAP) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)CompletedNCT06489756Not applicable1 country
- Effect of Oxygen Therapy for Patients With Precapillary Pulmonary Hypertension Who Experience an Altitude Related Adverse Health Effect (ARAHE) During 30h Exposure to 2500mCompletedNCT05112172Not applicable1 country
- Maximal Exercise Capacity at 2500 m of High AltitudeCompletedNCT05264324Not applicable1 country
- Altitude Related Adverse Health Effects (ARAHE) in Patients With Precapillary Pulmonary Hypertension During 30h Exposure to 2500mCompletedNCT05107700Not applicable1 country
- Exercise Endurance Time on the 2nd Day at 2500 m High AltitudeCompletedNCT05131737Not applicable1 country
- Nocturnal Oxygenation and Sleep-related Breathing Disorders During the First Night of a Stay at 2500m of High Altitude in Patients With Precapillary Pulmonary HypertensionCompletedNCT05089487Not applicable1 country
- Cerebral Tissue Oxygenation in Highlanders/LowlandersCompletedNCT031724291 country
- Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.CompletedNCT031650191 country
- Right Ventricular Function During Exercise in Highlanders/LowlandersCompletedNCT031650321 country
- Right Ventricular Function at Rest in Highlanders/LowlandersCompletedNCT031656561 country
- Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High AltitudeCompletedNCT02024386Phase 41 country
- Sleep Related Breathing Disturbances and High Altitude Pulmonary Hypertension in Kyrgyz HighlandersCompletedNCT016210611 country
- The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy VolunteersCompletedNCT01530464Phase 11 country
- The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary HypertensionCompletedNCT01566565Phase 11 country